Effectiveness of the tromboembolic venous disease treatments estimated through clinical trials vs. observational studies

E. Barbero Herranz (Madrid, Spain), C. Coscia (Madrid, Spain), A. Jaureguizar (Madrid, Spain), C. Quezada (Madrid, Spain), A. Muriel (Madrid, Spain), M. Monreal (Barcelona, Spain), T. Villén (Madrid, Spain), D. Chiluiza (Madrid, Spain), J. Yusen (Missouri y Cajal Hospital, United States of America), D. Jiménez (Madrid, Spain)

Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Session: Pulmonary embolism: from diagnosis to prognosis and treatment
Session type: Poster Discussion
Number: 3651
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Barbero Herranz (Madrid, Spain), C. Coscia (Madrid, Spain), A. Jaureguizar (Madrid, Spain), C. Quezada (Madrid, Spain), A. Muriel (Madrid, Spain), M. Monreal (Barcelona, Spain), T. Villén (Madrid, Spain), D. Chiluiza (Madrid, Spain), J. Yusen (Missouri y Cajal Hospital, United States of America), D. Jiménez (Madrid, Spain). Effectiveness of the tromboembolic venous disease treatments estimated through clinical trials vs. observational studies. 3651

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials
Source: Eur Respir J, 50 (3) 1701097; 10.1183/13993003.01097-2017
Year: 2017



Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Year: 2020




Interim results on European multi-center trial to evaluate the clinical utility of arteriovenous fistulae for treatment of severe COPD
Source: Annual Congress 2010 - Interventions for obstructive lung diseases
Year: 2010


Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017


Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019
Year: 2019



Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
Source: Eur Respir J 2009; 34: 231-242
Year: 2009



Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies
Source: Eur Respir J 2005; 26: Suppl. 49, 288s
Year: 2005

Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



Incidence of subdural hematoma in patients with pulmonary arterial hypertension (PAH) in two randomized controlled clinical trials
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012

Do we need controlled clinical trials in pulmonary arterial hypertension?
Source: Eur Respir J 2001; 17: 1-3
Year: 2001


Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study
Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017
Year: 2017



PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease
Source: Eur Respir J 2004; 24: Suppl. 48, 295s
Year: 2004